These terms and conditions govern your use of the website alphaminr.com and its related
services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr,
(“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms
include the provisions in this document as well as those in the Privacy Policy. These terms may
be modified at any time.
Subscription
Your subscription will be on a month to month basis and automatically renew every month. You may
terminate your subscription at any time through your account.
Fees
We will provide you with advance notice of any change in fees.
Usage
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Limitation of Liability
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The
service is provided “As is”. The materials and information accessible through the Service are
solely for informational purposes. While we strive to provide good information and data, we make
no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO
YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY
OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR
(2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE
CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR
CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision
shall not affect the validity or enforceability of the remaining provisions herein.
Privacy Policy
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal
information when we provide our service (“Service”). This Privacy Policy explains how
information is collected about you either directly or indirectly. By using our service, you
acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy
Policy, please do not use our Service. You should contact us if you have questions about it. We
may modify this Privacy Policy periodically.
Personal Information
When you register for our Service, we collect information from you such as your name, email
address and credit card information.
Usage
Like many other websites we use “cookies”, which are small text files that are stored on your
computer or other device that record your preferences and actions, including how you use the
website. You can set your browser or device to refuse all cookies or to alert you when a cookie
is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not
function properly. We collect information when you use our Service. This includes which pages
you visit.
Sharing of Personal Information
We use Google Analytics and we use Stripe for payment processing. We will not share the
information we collect with third parties for promotional purposes.
We may share personal information with law enforcement as required or permitted by law.
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
September 30, 2023
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
to
Commission File Number
001-33458
TERADATA CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
75-3236470
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification No.)
17095 Via Del Campo
San Diego
,
California
92127
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (
866
)
548-8348
Securities registered pursuant to Section 12(b) of the Act:
Title of each class:
Trading Symbol
Name of Each Exchange on which Registered:
Common Stock, $0.01 par value
TDC
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
ý
No
¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes
ý
No
¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
ý
Accelerated filer
¨
Non-accelerated filer
¨
Smaller reporting company
☐
Emerging growth company
☐
1
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
☐
No
ý
At
October 31, 2023
, the registrant had approximately
97.8
million
shares of common stock outstanding.
Preferred stock: par value $
0.01
per share,
100.0
shares authorized,
no
shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively
—
—
Common stock: par value $
0.01
per share,
500.0
shares authorized,
97.9
and
101.1
shares issued at September 30, 2023 and December 31, 2022, respectively
1
1
Paid-in capital
2,044
1,941
Accumulated deficit
(
1,797
)
(
1,565
)
Accumulated other comprehensive loss
(
126
)
(
119
)
Total stockholders’ equity
122
258
Total liabilities and stockholders’ equity
$
1,740
$
2,022
See Notes to Condensed Consolidated Financial Statements (Unaudited).
Notes to Condensed Consolidated Financial Statements (Unaudited)
1.
Basis of Presentation
These statements have been prepared pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC") and, in accordance with those rules and regulations, do not include all information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). In the opinion of management, the condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the results of operations, financial position and cash flows of Teradata Corporation ("Teradata" or the "Company") for the interim periods presented herein. The year-end 2022 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP. The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make use of estimates and assumptions that affect the reported amounts and disclosures. Actual results may vary from these estimates.
These condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in Teradata’s most recent Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the "2022 Annual Report"). The results of operations for any interim period are not necessarily indicative of the results of operations to be expected for the full year.
2.
New Accounting Pronouncements
The Compa
ny has assessed the Ac
counting Standards Updates and determined th
at they were not applicable or were not expected to have a material impact on the Company's financial statements.
Disaggregation of Revenue from Contracts with Customers
The following table presents a disaggregation of revenue:
Three Months Ended September 30,
Nine Months Ended September 30,
in millions
2023
2022
2023
2022
Americas
Recurring
$
231
$
207
$
717
$
668
Perpetual software licenses, hardware and other
2
5
10
20
Consulting services
31
30
97
93
Total Americas
264
242
824
781
EMEA
Recurring
87
77
263
241
Perpetual software licenses, hardware and other
4
6
16
20
Consulting services
22
22
69
76
Total EMEA
113
105
348
337
APJ
Recurring
42
47
140
153
Perpetual software licenses, hardware and other
1
3
7
8
Consulting services
18
20
57
64
Total APJ
61
70
204
225
Total Revenue
$
438
$
417
$
1,376
$
1,343
Rental revenue, which is included in recurring revenue in the above table, was as follows:
Three Months Ended September 30,
Nine Months Ended September 30,
in millions
2023
2022
2023
2022
Rental revenue*
$
56
$
45
$
163
$
140
*Rental revenue includes hardware maintenance.
Contract Balances
The timing of revenue recognition, billings and cash collections results in billed accounts receivable, contract assets, and customer advances and deposits (deferred revenue or contract liabilities) on the condensed consolidated balance sheet. Accounts receivable include amounts due from customers that are unconditional. Contract assets relate to the Company’s rights to consideration for goods delivered or services completed and recognized as revenue but billing and the right to receive payment is conditional upon the completion of other performance obligations. Contract assets are included in other current assets on the balance sheet and are transferred to accounts receivable when the rights become unconditional. Deferred revenue consists of advance payments and billings in excess of revenue recognized. Deferred revenue is classified as either current or noncurrent based on the timing of when the Company expects to recognize revenue. These assets and liabilities are reported on a contract-by-contract basis at the end of each reporting period.
The following table provides information about receivables, contract assets and deferred revenue from contracts with customers:
As of
in millions
September 30, 2023
December 31, 2022
Accounts receivable, net
$
286
$
364
Contract assets
$
11
$
7
Current deferred revenue
$
477
$
589
Long-term deferred revenue
$
16
$
8
Revenue recognized during the nine months ended September 30, 2023 from amounts included in deferred revenue at the beginning of the period was $
401
million.
Transaction Price Allocated to Unsatisfied Obligations
The following table includes estimated revenue expected to be recognized in the future related to the Company's unsatisfied (or partially satisfied) obligations at September 30, 2023:
in millions
Total at September 30, 2023
Year 1
Year 2 and Thereafter
Remaining unsatisfied obligations
$
2,394
$
1,409
$
985
The amounts above represent the price of firm orders for which work has not been performed or goods have not been delivered and exclude unexercised contract options outside the stated contractual term that do not represent material rights to the customer. Although the Company believes that the contract value in the above table is firm, approximately $
1,140
million of the amount is under contracts that are subject to customer-only general cancellation for convenience terms that the Company is contractually obligated to perform unless the customer notifies us of cancellation. The Company expects to recognize revenue of approximately $
503
million in the next year from contracts that are non-cancelable. The Company believes the inclusion of this information is important to understanding the obligations that the Company is contractually required to perform and provides useful information regarding remaining obligations related to these executed contracts.
4.
Contract Costs
The Company capitalizes sales commissions and other contract costs that are incremental direct costs of obtaining customer contracts if the expected amortization period of the asset is greater than one year. These costs are recorded in capitalized contract costs, net on the Company’s balance sheet. The capitalized amounts are calculated based on the annual recurring revenue and contract value for individual multi-term contracts. The judgments made in determining the amount of costs incurred include whether the commissions are in fact incremental and would not have occurred absent the customer contract. Costs to obtain a contract are amortized as selling, general and administrative expenses on a straight-line basis over the expected period of benefit, which is typically around
four years
. These costs are periodically reviewed for impairment.
The following table identifies the activity relating to capitalized contract costs:
Income tax provisions for interim periods are based on estimated annual income tax rates, adjusted to reflect the effects of any significant infrequent or unusual items which are required to be discretely recognized within the current interim period. The Company expects that a majority of its foreign earnings will be repatriated back to the United States ("U.S."). As a result, the effective tax rates in the periods presented are largely based upon the forecasted pre-tax earnings mix and allocation of certain expenses in various taxing jurisdictions where the Company conducts its business.
The effective tax rate is as follows:
Three Months Ended September 30,
Nine Months Ended September 30,
In millions
2023
2022
2023
2022
Effective tax rate
7.7
%
20.0
%
27.4
%
38.5
%
For the three months ended September 30, 2023, the Company recorded
$
4
million
of net discrete tax benefits, a majority of which related to adjustments to the Company's accrual for unrecognized tax benefits in accordance with FIN 48 for the lapse of statute of limitations.
For the nine months ended September 30, 2023, the Company recorded
$
6
million
of net discrete tax benefits, $
3
million of which related to adjustments to the Company's accrual for unrecognized tax benefits in accordance with FIN 48 and $
3
million related to the excess tax benefit derived from stock-based compensation vesting.
For the three months ended September 30, 2022, the Company had
no
material discrete tax adjustments.
For the nine months ended September 30, 2022, the Company recorded
$
2
million
of net discrete tax benefits, a majority of which related to the excess tax benefit derived from $
6
million of stock compensation vesting, offset by $
5
million of discrete tax expense associated with valuation allowances against the current tax receivable and deferred tax asset balance that is not expected to be realized as a result of the discontinuation of the Company’s business in Russia in the first quarter of 2022. As a result of these discrete items the Company recorded income tax
expense of $
25
million on a pre-tax income of $
65
million for the nine months ended September 30, 2022, resulting in an effective income tax rate of
38.5
%.
The Company estimates its annual effective tax rate for 2023 to be approximately
40.0
%
, which takes into consideration, among other things, the forecasted earnings mix by jurisdiction and the impact of discrete tax items to be recognized in 2023. Under U.S. tax law, U.S. shareholders are subject to a tax on global intangible low-taxed income ("GILTI") earned by certain foreign subsidiaries. The Company has elected to provide for the tax expense related to GILTI in the year in which the tax is incurred. Effective on January 1, 2022, the U.S. tax law changed and now requires R&D expenses to be capitalized and amortized for tax purposes under Internal Revenue Code Section 174. The Company is currently forecasting approximately
$
2
million
of tax expense related to GILTI in our marginal effective tax rate for 2023.
7.
Derivative Instruments and Hedging Activities
As a portion of Teradata’s operations is conducted outside the U.S. and in currencies other than the U.S. dollar, the Company is exposed to potential gains and losses from changes in foreign currency exchange rates. In an attempt to mitigate the impact of currency fluctuations, the Company uses foreign exchange forward contracts to hedge transactional exposures resulting predominantly from foreign currency denominated inter-company receivables and payables. The forward contracts are designated as fair value hedges of specified foreign currency denominated inter-company receivables and payables and generally mature in three months or less. The fair values of foreign exchange contracts are based on market spot and forward exchange rates and represent estimates of possible value that may not be realized in the future. Across its portfolio of contracts, Teradata has both long and short positions relative to the U.S. dollar. As a result, Teradata’s net exposure is less than the total contract notional amount of the Company’s foreign exchange forward contracts.
Gains and losses from foreign exchange forward contracts are fully recognized each period and reported along with the offsetting gain or loss of the related hedged item, either in cost of revenues, operating expenses or in other income (expense), depending on the nature of the related hedged item.
During June 2022, Teradata entered into a cross-currency swap designated as a net investment hedge, to hedge the Euro currency exposure of its net investment in certain foreign subsidiaries. This agreement is a contract to exchange fixed-rate payments in one currency for fixed-rate payments in another currency. Changes in the fair value of this swap are recorded in Accumulated Other Comprehensive Loss in the same manner as foreign currency translation adjustments. In assessing the effectiveness of this hedge, the Company used a method based on changes in spot rates to measure the impact of the foreign currency exchange rate fluctuations on both its foreign subsidiary net investment and the related swap.
The cross-currency swap contract has an expiration date of June 29, 2026. At maturity of the cross-currency swap contract, the Company will
deliver
the notional amount of €
143
million and wil
l receive
$
150
million from the counterparty. The Company will receive monthly interest payments from the counterparty based on a fixed interest rate until maturity of the agreements.
In June 2022, Teradata refinanced its long-term debt and its associated interest rate swap ("Prior Interest Rate Swap"), which were due to mature in June 2023. As a result, Teradata terminated its
five-year
London Interbank Offered Rate ("Libor") interest rate swap that had a $
500
million initial notional amount to hedge the floating interest rate of its Libor term loan. On June 28, 2022, Teradata executed a
five-year
Secured Overnight Financing Rate ("SOFR") interest rate swap, to fix the interest rate on approximately
90
% of the principal balance of the $
500
million term loan, with an initial notional amount of $
450
million. The Company uses interest rate swaps to manage interest rate risks on future interest payments caused by interest rate changes on its variable rate term loan. The notional amount of the hedge steps down according to the amortization schedule of the term loan. The notional amount of the hedge was $
450
million as of September 30, 2023.
The Company performed an initial effectiveness assessment on the interest rate swap and the net investment hedge foreign currency swap, and the hedges were determined to be effective. The hedges are being evaluated qualitatively on a quarterly basis for effectiveness. Changes in fair value are recorded in Accumulated Other Comprehensive Loss and periodic settlements of the swap will be recorded in interest expense along with the interest on amounts outstanding under the term loan.
The following table identifies the contract notional amount of the Company’s derivative financial instruments:
Contract notional amount of foreign exchange forward contracts
$
73
$
46
Net contract notional amount of foreign exchange forward contracts
$
17
$
7
Contract notional amount of foreign currency exchange (net investment hedge)
$
150
$
150
Contract notional amount of interest rate swap
$
450
$
450
All derivatives are recognized in the condensed consolidated balance sheets at their fair value. The notional amounts represent agreed-upon amounts on which calculations of dollars to be exchanged are based and are an indication of the extent of Teradata’s involvement in such instruments. These notional amounts do not represent amounts exchanged by the parties and, therefore, are not a measure of the instruments. Refer to Note 9 for disclosures related to the fair value of all derivative assets and liabilities.
The Company does not hold or issue derivative financial instruments for trading purposes, nor does it hold or issue leveraged derivative instruments. By using derivative financial instruments to hedge exposures to changes in foreign exchange and interest rates, the Company exposes itself to credit risk. The Company manages exposure to counterparty credit risk by entering into derivative financial instruments with highly rated institutions that can be expected to fully perform under the terms of the applicable contracts.
8.
Commitments and Contingencies
Legal Proceedings.
In the ordinary course of business, the Company is subject to proceedings, lawsuits, governmental investigations, claims and other matters, including those that relate to the environment, health and safety, employee benefits, export compliance, intellectual property, tax matters and other regulatory compliance and general matters. It is not currently a party to any litigation, nor is it aware of any pending or threatened litigation against it that the Company believes would materially affect its business, operating results, financial condition or cash flows, other than the following.
On June 19, 2018, the Company and certain of its subsidiaries filed a lawsuit (the "TD-SAP 1" suit) in the U.S. District Court for the Northern District of California against SAP SE, SAP America, Inc., and SAP Labs, LLC (collectively, "SAP"). In the TD-SAP 1 lawsuit, the Company alleged, among other things, that SAP misappropriated certain of the Company’s trade secrets within the Company’s enterprise data analytics and warehousing products and used such trade secrets to help develop, improve, introduce, and sell one or more competing products. The Company further alleged that SAP employed anticompetitive practices using its substantial market position in the enterprise resource planning applications market to pressure the Company’s customers and prospective customers to use one or more of SAP's competing products and reduce or eliminate customers' and prospective customers' use of the Company's offerings. The Company sought an injunction barring SAP’s alleged conduct, monetary damages, and other available legal and equitable relief. In July 2019, SAP filed patent infringement counterclaims against the Company based on
five
of SAP’s U.S. patents. On August 31, 2020, the Company filed a second lawsuit against SAP (the "TD-SAP 2" suit) in the U.S. District Court for the Northern District of California, in which the Company alleged infringement by SAP of
four
of the Company's U.S. patents. On February 16, 2021, SAP filed additional patent infringement counterclaims against the Company in response. On the same day, SAP also filed a lawsuit in Germany (the "TD-SAP 3" suit) for infringement of a single German patent. In November 2021, the district court dismissed the Company’s antitrust claims and most of its trade secret claims in the TD-SAP 1 suit. In December 2021, the Company appealed that decision to the U.S. Court of Appeals for the Federal Circuit in Washington, D.C. and the Court held a hearing on that appeal on June 8, 2023. On August 1, 2023, the Federal Circuit transferred the appeal to the Ninth Circuit Court of Appeals, and the parties anticipate the appeal will be heard there in the first quarter of 2024. In the meantime, the Company and SAP have entered into a partial settlement agreement that has resulted in full dismissal of all claims and counterclaims in the TD-SAP 2 suit in California and the TD-SAP 3 suit in Germany as well as a stay of all claims and counterclaims remaining in the TD-SAP 1 suit pending resolution of the Company’s appeal. Currently, it is not possible to determine the likelihood of a loss or a reasonably estimated range of loss, if any, pertaining to any of SAP’s remaining patent counterclaims in the TD-SAP 1 lawsuit.
Other Contingencies.
The Company provides its customers with certain indemnification rights. In general, the Company agrees to indemnify the customer if a third party asserts patent or other infringement on the part of the customer for its use of the Company’s offerings. The Company has indemnification obligations under its charter and bylaws to its officers and directors, and has entered into indemnification agreements with the officers and directors of its subsidiaries. From time to time, the Company also enters into agreements in connection with its acquisition and divestiture activities that include indemnification obligations by the Company. The fair value of these indemnification obligations is typically not readily determinable due to the conditional nature of the Company’s potential obligations and the specific facts and circumstances involved with each particular agreement. As such, the Company has generally not recorded a liability in connection with these indemnification arrangements. Historically, payments made by the Company under these types of agreements have not had a material effect on the Company’s consolidated financial condition, results of operations or cash flows.
Concentrations of Risk
. The Company is potentially subject to concentrations of credit risk on accounts receivable and financial instruments such as hedging instruments, and cash and cash equivalents. Credit risk includes the risk of nonperformance by counterparties. The maximum potential loss may exceed the amount recognized on the balance sheet. Exposure to credit risk is managed through credit approvals, credit limits, selecting major international financial institutions (as counterparties to hedging transactions) and monitoring procedures. Teradata’s business often involves large transactions with customers, and if one or more of those customers were to default in its obligations under applicable contractual arrangements, the Company could be exposed to potentially significant losses. However, management believes that the reserves for potential losses were adequate at September 30, 2023 and December 31, 2022.
The Company is also potentially subject to concentrations of supplier risk. Our hardware components are assembled exclusively by Flex Ltd. ("Flex"). Flex procures a wide variety of components used in the manufacturing process on behalf of the Company. Although many of these components are available from multiple sources, Teradata utilizes preferred supplier relationships to provide more consistent and optimal quality, cost and delivery. Typically, these preferred suppliers maintain alternative processes and/or facilities to ensure continuity of supply. Given the Company’s strategy to outsource its manufacturing activities to Flex and to source certain components from single suppliers, a disruption in production at Flex or at a supplier could impact the timing of customer shipments and/or Teradata’s operating results. In addition, a significant change in the forecasts to any of these preferred suppliers could result in purchase obligations for components that may be in excess of demand.
9.
Fair Value Measurements
Fair value measurements are established utilizing a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets for identical assets or liabilities; Level 2, defined as significant other observable inputs, such as quoted prices in active markets for similar assets or liabilities, or quoted prices in less-active markets for identical assets; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.
The Company’s assets and liabilities measured at fair value on a recurring basis include money market funds, interest rate swaps, foreign currency swaps and foreign currency exchange contracts. A portion of the Company’s excess cash reserves are held in money market funds which generate interest income based on the prevailing market rates. Money market funds are included in cash and cash equivalents in the Company’s balance sheet. Money market fund holdings are measured at fair value using quoted market prices and are classified within Level 1 of the valuation hierarchy.
When deemed appropriate, the Company minimizes its exposure to changes in foreign currency exchange rates through the use of derivative financial instruments, specifically, foreign exchange forward contracts. Additionally, in June 2022, Teradata executed a
five-year
interest rate swap with a $
450
million initial notional amount in order to hedge the variable interest rate on its term loan and a
four-year
cross-currency swap with initial notional amounts of €
143
million/$
150
million, as a net investment hedge to hedge the Euro currency exposure of our net investment in certain foreign subsidiaries. The fair value of these contracts and swaps are measured at the end of each interim reporting period using observable inputs other than quoted prices, specifically market spot and forward exchange rates. As such, these derivative instruments are classified within Level 2 of the valuation hierarchy. Fair value of
unrealized gains for open contracts are recorded in other assets and the fair value of unrealized losses are recorded in other liabilities in the Company's balance sheet. The fair value of foreign exchange forward contract assets and liabilities at September 30, 2023 and December 31, 2022 was not material. Realized gains and losses from the Company’s fair value and net investment hedges net of corresponding gains or losses on the underlying exposures were immaterial for the three and nine months ended September 30, 2023 and 2022.
The Company’s other assets and liabilities measured at fair value on a recurring basis and subject to fair value disclosure requirements at September 30, 2023 and December 31, 2022 were as follows:
Fair Value Measurements at Reporting Date Using
In millions
Total
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Assets
Money market funds at September 30, 2023
$
54
$
54
$
—
$
—
Money market funds at December 31, 2022
$
211
$
211
$
—
$
—
Interest rate swap at September 30, 2023
$
20
$
—
$
20
$
—
Interest rate swap at December 31, 2022
$
13
$
—
$
13
$
—
Liabilities
Foreign currency swap at September 30, 2023
$
2
$
—
$
2
$
—
Foreign currency swap at December 31, 2022
$
1
$
—
$
1
$
—
10.
Debt
On June 28, 2022, the Company entered into a Credit Agreement that provides for (i) a
five-year
unsecured term loan in an aggregate principal amount of $
500
million (the "Term Loan"), and (ii) a
five-year
unsecured revolving credit facility in an aggregate principal amount of up to $
400
million, including a $
50
million sublimit for the issuance of standby letters of credit and a $
50
million sublimit for swingline loans (the "Revolving Facility" and, collectively with the Term Loan, the "Credit Facility"). The Credit Facility replaces the Company's prior revolving credit agreement in the maximum principal of $
400
million and its prior term loan agreement in the initial principal amount of $
500
million, both of which were entered into in 2018 (the "Prior Agreements"). In connection with the execution of the Credit Facility, the $
400
million term loan outstanding under the Prior Agreements was repaid in full.
All outstanding borrowings pursuant to the Revolving Facility are due and payable on June 28, 2027, however, the maturity date of the Revolving Facility may be extended by agreement of the parties for up to
two
additional
one-year
periods. The Term Loan is payable in quarterly installments, which commence on June 30, 2024, with
1.25
% of the initial principal amount due on each of the first
twelve
payment dates, with all remaining principal due on June 28, 2027. Under the terms of the Credit Facility, Teradata from time to time and subject to certain conditions may increase the lending commitments under the Credit Facility in an aggregate principal amount up to an additional $
450
million, to the extent that existing or new lenders agree to provide such additional commitments. The outstanding principal amount of the Credit Facility bears interest at a floating rate based upon, at Teradata’s option, a negotiated base rate or an adjusted term SOFR rate, plus in each case, a margin based on the Company's leverage ratio. As disclosed in Note 7, in June 2022, Teradata entered into an interest rate swap to hedge approximately
90
%
(or
$
450
million
as of September 30, 2023) of the floating interest rate of the total $
500
million Term Loan and a cross currency swap to hedge a portion of Euro currency exposure of its net investment in certain foreign subsidiaries.
The Credit Facility is unsecured but is guaranteed by certain of Teradata’s material domestic subsidiaries and contains certain customary representations and warranties, default provisions, and affirmative and negative covenants, including, among others, covenants regarding the maintenance of a leverage ratio and covenants relating to financial reporting, compliance with laws, subsidiary indebtedness, liens, sale and leaseback transactions, mergers and other fundamental changes, and entry into certain restrictive agreements. Most of the covenants are
subject to materiality, thresholds, and exceptions. On September 21, 2023, the Credit Agreement was amended to establish key performance indicators with respect to certain environmental, social, and governance ("ESG") targets, pursuant to which certain positive or negative adjustments would be made to various fees and applicable margin based on Teradata’s performance against such ESG targets.
As of September 30, 2023, the Company had
no
borrowings outstanding under the Revolving Facility, leaving $
400
million in borrowing capacity available under the Revolving Facility and the Term Loan principal outstanding was
$
500
million
. The Term Loan is recognized on the Company's balance sheet at the unpaid principal balance, net of deferred issuance costs, and is not subject to fair value measurement. The Company was
in compliance
with all covenants under the Credit Facility as of September 30, 2023.
For the three months ended September 30, 2023 and September 30, 2022, the blended all-in interest rate on the Credit Facility was
4.45
%
and
3.98
%, respectively.
11.
Earnings per Share
Basic earnings per share is calculated by dividing net income by the weighted average number of shares outstanding during the reported period. The calculation of diluted earnings per share is similar to basic earnings per share, except that the weighted average number of shares outstanding includes the dilution from potential shares resulting from stock options, restricted stock awards and other stock awards.
The components of basic and diluted earnings per share are as follows:
Three Months Ended
September 30,
Nine Months Ended September 30,
In millions, except per share amounts
2023
2022
2023
2022
Net income attributable to common stockholders
$
12
$
8
$
69
$
40
Weighted average outstanding shares of common stock
99.2
102.7
100.5
103.7
Dilutive effect of employee stock options, restricted stock and other stock awards
2.8
2.0
2.3
2.7
Common stock and common stock equivalents
102.0
104.7
102.8
106.4
Net income per share:
Basic
$
0.12
$
0.08
$
0.69
$
0.39
Diluted
$
0.12
$
0.08
$
0.67
$
0.38
Options to purchase
0.1
million shares for the nine months ended September 30, 2023 and
0.4
million shares in each of the three and nine months ended September 30, 2022 were not included in the computation of diluted earnings per share because the exercise prices of these options were greater than the average market price of the common shares for the period, and therefore would have been anti-dilutive. There were
no
anti-dilutive options excluded for the three months ended September 30, 2023.
12.
Segment and Other Supplemental Information
Teradata manages its business under
three
geographic regions, which are also the Company’s operating segments: (1) Americas region (North America and Latin America); (2) EMEA region (Europe, Middle East and Africa) and (3) APJ region (Asia Pacific and Japan). For purposes of discussing results by segment, management excludes the impact of certain items, consistent with the manner by which management evaluates the performance of each segment. This format is useful to investors because it allows analysis and comparability of operating trends. It also includes the same information that is used by Teradata management to make decisions regarding the segments and to assess financial performance. The chief operating decision maker, who is the Company's President and Chief Executive Officer, evaluates the performance of the segments based on revenue and multiple profit measures, including segment gross profit. For management reporting purposes, assets are not allocated to the segments.
The following table presents segment revenue and segment gross profit for the Company:
Three Months Ended
September 30,
Nine Months Ended September 30,
In millions
2023
2022
2023
2022
Segment revenue
Americas
$
264
$
242
$
824
$
781
EMEA
113
105
348
337
APJ
61
70
204
225
Total revenue
438
417
1,376
1,343
Segment gross profit
Americas
164
151
521
493
EMEA
67
66
214
207
APJ
33
44
115
136
Total segment gross profit
264
261
850
836
Stock-based compensation costs
4
3
12
12
Acquisition, integration, reorganization and transformation-related costs
1
(
1
)
1
6
Total gross profit
259
259
837
818
Selling, general and administrative expenses
156
155
476
475
Research and development expenses
76
79
222
236
Income from operations
$
27
$
25
$
139
$
107
13.
Subsequent Events
Argentina Blue Chip Swap Transaction
The Central Bank of Argentina maintains currency controls that limit our ability to access U.S. dollars in Argentina and remit cash from our Argentine operations. There is a foreign exchange mechanism known as Blue Chip Swaps, which effectively results in a parallel U.S. dollar exchange rate. This parallel rate, which cannot be used as the basis to remeasure our net monetary assets in U.S. dollars under U.S. GAAP, was approximately
168
% higher than Argentina’s official exchange rate at September 30, 2023. During October of 2023, we began entering into Blue Chip Swap transactions in order to remit cash from our Argentine operations that will result in a pre-tax loss on investment of $
13
million during the fourth quarter of 2023.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations ("MD&A").
You should read the following discussion in conjunction with the Condensed Consolidated Financial Statements (Unaudited) and the notes to those statements included elsewhere in this Quarterly Report on Form 10-Q. This Quarterly Report on Form 10-Q contains certain statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Certain statements contained in the MD&A are forward-looking statements that involve risks and uncertainties. The forward-looking statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry, business and future financial results. Our actual results could differ materially from the results contemplated by these forward-looking statements due to a number of factors, including those discussed in other sections of this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the "2022 Annual Report"). The Company does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
At Teradata Corporation ("we," "us," "Teradata," or the "Company"), we believe that people thrive when empowered with better information. That's why we built our comprehensive cloud analytics and data platform, including for Artificial Intelligence ("AI"). By delivering harmonized data, trusted AI, and faster innovation, we believe that we uplift and empower our customers - and our customers' customers - to make better, more confident decisions. Teradata's platforms are designed to improve business performance, enrich customer experiences, and fully integrate data across the enterprise. We believe that we drive positive impact for hundreds of millions of people every day around the world with faster, flexible data integration and trusted, cost-effective AI innovation.
Across the company, we are executing to advance in our transformation as a leading cloud analytics and data platform. We experienced an increase in customer demand in the third quarter of 2023 as enterprises continue to use our industry-recognized platform to drive business-critical insights, accelerate value realization, and enable their use of AI and machine learning ("ML"). Our cloud native Teradata VantageCloud Lake, with its data management capability and workload efficiency, and ClearScape Analytics
TM
, our analytics capabilities in VantageCloud, are designed to deliver harmonized data, trusted AI/ML, and faster innovation to facilitate better decision-making. In the third quarter of 2023, we believe that several innovations and transactions occurred that position Teradata to lead in trusted AI enablement, including:
•
Teradata VantageCloud Lake on Microsoft Azure. Now, our cloud native architecture is available on both AWS and Azure globally and is designed to offer the enterprise scale our customers need, including end-to-end support for AI and ML.
•
We acquired Stemma Technologies which provided data catalog capabilities that we expect will add AI-enhanced data search and exploration to our platform.
•
Teradata ask.ai, our new gen AI capability for VantageCloud Lake that was released for use by select customers in private preview.
•
Teradata included new ModelOps capabilities in ClearScape Analytics, which is intended to bring no-code capabilities to enable customers to quickly scale AI and advanced analytics with enterprise governance.
To allow for greater transparency regarding the progress we are making toward achieving our strategic objectives, we utilize the following financial and performance metrics:
•
Total Annual Recurring Revenue ("ARR") - annual value at a point in time of all recurring contracts, including subscription, cloud, software upgrade rights, and maintenance. ARR does not include managed services and third-party revenue.
•
Public Cloud ARR (included within total ARR) - annual value at a point in time of all recurring contracts related to public cloud implementations of Teradata VantageCloud and does not include ARR related to private or managed cloud implementations.
•
Cloud Net Expansion Rate - Teradata calculates its last-twelve months dollar-based cloud net expansion rate as of a fiscal quarter end as follows:
◦
Identify ARR for active cloud customers in the fiscal quarter ending one year prior to the given fiscal quarter (the "base period");
◦
Identify Public Cloud ARR in the given fiscal quarter (the "current period") from the same set of active cloud customers as the base period, including increases in usage, as well as reductions and cancellations, and additional conversions of on-premises revenues to the cloud for customers active in the base period, all in constant currency;
◦
Cloud net expansion rate is calculated by taking the ARR from the current period and dividing by the ARR from the base period (all quarterly-dollar based); and
◦
The last twelve-month dollar-based cloud net expansion rate is calculated by taking the average of the quarterly dollar-based cloud net expansion rate from the last fiscal quarter and the prior three fiscal quarters.
COVID-19 Update
There have not been any material changes to the COVID-19 Update previously disclosed in Part I, Item 1A. "Risk Factors" and Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the 2022 Annual Report.
As more fully discussed in later sections of this MD&A, the following were significant financial items for the third quarter of 2023:
•
At the end of the third quarter of 2023, ARR was
$1.524
billion compared to
$1.374
billion in the
third
quarter of 2022,
increasing
11%
as compared to the third quarter of 2022, including a 2% positive impact from foreign currency translation.
•
At the end of third quarter of 2023, Public Cloud ARR was
$454
million compared to $279 million in the
third
quarter of 2022,
increasing 63%
as compared to the
third
quarter of 2022, including a 2% positive
i
mpact from foreign currency fluctuations.
•
Total revenue was
$438 million
for the third quarter of 2023, a
5%
increase
compared to the third quarter of 2022, with a
9%
increase
in recurring revenue. Perpetual software licenses, hardware and other revenue
decreased 50%
, and consulting services revenue decreased
1%
. Foreign currency fluctuations had a
1%
adverse i
mpact on total revenue for the quarter compared to the prior year.
•
Gross margin
decreased
to
59.1%
in the third quarter of 2023 from 62.1% in the third quarter of 2022, primarily due to lower consulting margins, as well as revenue mix with a higher percentage of Public Cloud revenue, offset in part by improving margin rates of Public Cloud revenue as compared to the third quarter of 2022.
•
Operating expenses for the third quarter of 2023 were
relatively flat c
ompared to the third quarter of 2022, as
slightly lower research and development expenses were partially offset by higher
selling, general and administrative expenses in the third quarter of 2023.
•
Operating income was
$27 million
in the third quarter of 2023, compared to $25 million in the third quarter of 2022.
•
Net income in the third quarter of 2023 was
$12 million
, compared to $8 million in the third quarter of 2022.
•
Cloud Net Expansion Rate for the third quarter of 2023 was
123%
, compared to
117
% for the
third
quarter of 2022.
Results of Operations for the Three Months Ended September 30, 2023
Compared to the Three Months Ended September 30, 2022
Revenue
% of
% of
In millions
2023
Revenue
2022
Revenue
Recurring
$
360
82.2
%
$
331
79.3
%
Perpetual software licenses, hardware and other
7
1.6
%
14
3.4
%
Consulting services
71
16.2
%
72
17.3
%
Total revenue
$
438
100
%
$
417
100
%
Total revenue
increased
$
21
million, or
5%
, in the third quarter of 2023, including a
1%
negative
impact from foreign currency fluctuations. Recurring revenue
increased
by
9%
, including a
1% negative
impact from foreign currency fluctuations. The recurring revenue
increase
was due primarily to Public Cloud revenue growth across all three operating regions and various industry verticals. Revenues from perpetual software licenses, hardware and other de
creased 50%
, or $
7 million
in the third quarter of 2023
, primarily due t
o the timing of deals and a low overall volume from this revenue category, as aligned with our strategic shift towards recurring revenue. Consulting services revenue decreased 1% in the third quarter of 2023, reflecting a consulting business that is stabilizing its revenue run-rate, as anticipated
.
Financial and Performance Measures
Our ARR is composed of three main categories: (1) Public Cloud ARR, (2) ARR related to on-premises subscription-based contracts and private cloud ("Subscription ARR"), and (3) ARR related to our legacy perpetual maintenance and software upgrade rights. At September 30, our ARR consisted of:
In millions
2023
2022
Public Cloud
$
454
$
279
Subscription
872
802
Maintenance and Software upgrade rights
198
293
Total ARR
$
1,524
$
1,374
Cloud Net Expansion rate
123
%
117
%
At the end of the third quarter of 2023, total ARR
increased 11%
as compared to the third quarter of 2022, including a 2% positive impact from foreign currency fluctuations. At the end of the third quarter of 2023, Public Cloud ARR
increased 63%
as compared to the
third
quarter of 2022, including a 2% positive impact from foreign currency fluctuations. Public Cloud ARR
grew
in all three geographic regions year-over-year. Public Cloud ARR
growth
in the
third
quarter of 2023 was driven by greater market awareness and customer demand.
In the third quarter, we experienced the following continuing trends:
•
Increasing number of existing cloud customers who are adding new, incremental workloads to the cloud.
•
Customers expanding into additional cloud capabilities when they migrate to VantageCloud as compared to the capabilities they had in an on-premises environment.
•
Existing on-premises customers are adding new, incremental cloud workloads when expanding into hybrid environments.
As a portion of the Company’s operations and revenue occur outside the United States, and in currencies other than the U.S. dollar, the Company is exposed to fluctuations in foreign currency exchange rates. Based on currency rates as of October 31, 2023, Teradata is now estimating a 2.0%-to-2.5% negative impact from currency translation on our 2023 full-year total reported revenues, reflecting an incremental unplanned negative currency impact as compared to expectations from currency rates as of July 31, 2023.
The
decrease
in recurring revenue gross profit as a percentage of revenue was primarily due to a higher mix of cloud revenues versus on-premises revenue as compared to the prior-year period. Recurring revenue gross profit increased on a dollar basis due to both higher volumes and improving cloud gross profit rates year-over-year.
The
decrease
in perpetual software licenses, hardware and other gross profit as a percentage of revenue was primarily driven by deal mix and the timing of revenue.
Consulting services gross profit a
s a percentage of revenue
decreased
as c
ompared to the prior year
primarily due to headcount expenses and delayed project timelines.
Operating Expenses
% of
% of
In millions
2023
Revenue
2022
Revenue
Selling, general and administrative expenses
$
156
35.6
%
$
155
37.2
%
Research and development expenses
76
17.4
%
79
18.9
%
Total operating expenses
$
232
53.0
%
$
234
56.1
%
Selling, general and administrative ("SG&A") expense was roughly flat year over year. Research and development ("R&D") expense
decreased
year over year due to continued cost discipline and lower outside services costs.
Other Expense, net
In millions
2023
2022
Interest income
$
7
$
4
Interest expense
(8)
(6)
Other
(13)
(13)
Other expense, net
$
(14)
$
(15)
Other expense, net in the third quarter of 2023 and 2022 is comprised primarily of interest expense on long-term debt and finance leases,
losses
resulting from foreign currency transactions, as well as benefit costs on our pension and postemployment plans, partially offset by interest income earned on our cash and cash equivalents. Other expense is
lower
in 2023 primarily due to
decreased foreign currency losses of $1 million
as compared to the prior period.
As disclosed in Note 13 of Notes to Condensed Consolidated Financial Statements (Unaudited), during October of 2023, we began entering into Blue Chip Swap transactions in order to remit cash from our Argentine operations that will result in a pre-tax loss on investment of
$13 million
during the fourth quarter of 2023 that will be reported in "Other" expense in the fourth quarter of 2023.
Provision for Income Taxes
Income tax provisions for interim periods are based on estimated annual income tax rates, adjusted to reflect the effects of any significant infrequent or unusual items which are required to be discretely recognized within the current interim period.
The effective tax rates for the three months ended September 30, 2023 and 2022 were as follows:
For the three months ended September 30, 2023, the Company
recorded $4 million of net discrete tax benefit, a majority of which related to adjustments to the Company's accrual for unrecognized tax benefits in accordance with FIN 48 for the lapse of statute of limitations.
For the three months ended September 30, 2022, the Company had
no
material discrete tax adjustments.
Effective on January 1, 2022, the U.S. tax law changed to require that R&D expenses be capitalized and amortized for tax purposes under Internal Revenue Code Section 174. This requirement has an impact on global intangible low-taxed income ("GILTI") tax. We are currently forecasting approximately
$2 million
of tax expense related to GILTI in our marginal effective tax rate for 2023.
We expect that a majority of our foreign earnings will be repatriated to the U.S. As a result, the effective tax rates in the periods presented are largely based upon the forecasted pre-tax earnings mix between the U.S. and other foreign taxing jurisdictions where we conduct our business.
We estimate that the full-year effective tax rate for 2023 will be approximately
40%
, which takes into consideration, among other things, the forecasted earnings mix by jurisdiction, the estimated impact to GILTI tax (including the requirement to capitalize R&D for tax purposes), and the estimated discrete items to be recognized in 2023. The forecasted tax rate is based on the foreign profits being taxed at an overall effective tax rate of approximately
30%, which includes the $8 million net tax impact related to the execution of the Blue Chip Swap in the fourth quarter of 2023 as disclosed in
Note 13 of Notes to Condensed Consolidated Financial Statements (Unaudited),
as compared to the U.S. federal statutory tax rate of
21%
.
Teradata manages its business under three geographic regions, which are also our operating segments: (1) Americas region (North America and Latin America); (2) EMEA region (Europe, Middle East, and Africa) and (3) APJ region (Asia Pacific and Japan). For purposes of discussing results by segment, management excludes the impact of certain items, consistent with the manner by which management evaluates the performance of each segment. This format is useful to investors because it allows analysis and comparability of operating trends. It also includes the same information that is used by our management to make decisions regarding the segments and to assess financial performance. The chief operating decision maker, who is our President and Chief Executive Officer, evaluates the performance of the segments based on revenue and multiple profit measures, including segment gross profit. For management reporting purposes, assets are not allocated to the segments. Our segment results are reconciled to total company results reported under GAAP in Note 12 of Notes to Condensed Consolidated Financial Statements (Unaudited).
The following table presents segment revenue and segment gross profit for the Company for the three months ended September 30:
% of
% of
In millions
2023
Revenue
2022
Revenue
Segment revenue
Americas
$
264
60.3
%
$
242
58.0
%
EMEA
113
25.8
%
105
25.2
%
APJ
61
13.9
%
70
16.8
%
Total segment revenue
$
438
100
%
$
417
100
%
Segment gross profit
Americas
$
164
62.1
%
$
151
62.4
%
EMEA
67
59.3
%
66
62.9
%
APJ
33
54.1
%
44
62.9
%
Total segment gross profit
$
264
60.3
%
$
261
62.6
%
Americas
Americas revenue
increased 9% as
compared to the prior year, including a
2% adverse i
mpact from foreign currency fluctuations. The
increase
in revenues was due to an
increase
in recurring revenue
of
12%
, a
consulting revenue increase of 3%
($
1
million), partially offset by a 60% decrease ($3 million) in perpetual software licenses, hardware and other revenue, as compared to the prior year. Segment gross profit as a percentage of revenues was
relatively flat as compared to the prior year period.
EMEA
EMEA revenue
increased 8%
, including a
5% favorable i
mpact from foreign currency fluctuations. The overall
increase i
n EMEA revenue included an
increase of 13% in re
curring revenue, partially off-set by a
decrease
of
33% ($2 million) i
n perpetual software licenses, hardware and other revenue. Consulting revenue was flat year over year. Segment gross profit as a percentage of revenues was
lower
primarily due to a decline in consulting gross profit rates, which were impacted by headcount expenses and delayed project timelines.
APJ
APJ revenue
decreased 13%, in
cluding a 5
% adverse i
mpact from foreign currency fluctuations. Recurring revenue
decreased by 11%
($
5
million), perpetual software licenses, hardware and other revenue
decreased
by
67% ($2 million), and consulting revenue decreased by 10% ($2 million). The decline in total revenue was primarily
impacted by our strategic decision to wind-down direct operations in China earlier this year. Segment gross profit as a percentage of revenues was
lower
primarily due
to the reduced revenues in China
as well as lower consulting gross profit rates.
Results of Operations for the Nine Months Ended September 30, 2023
Compared to the Nine Months Ended September 30, 2022
Revenue
% of
% of
In millions
2023
Revenue
2022
Revenue
Recurring
$
1,120
81.4
%
$
1,062
79.1
%
Perpetual software licenses, hardware and other
33
2.4
%
48
3.6
%
Consulting services
223
16.2
%
233
17.3
%
Total revenue
$
1,376
100
%
$
1,343
100
%
Total revenue
increased $33 million
, or
2%,
in the first nine months of 2023, and included a
3% adverse
impact from foreign currency fluctuations. Total revenue was adversely impacted by the loss of the partial period of revenue recognized from the Company's Russia operations in 2022, prior to exiting that business late in the first quarter of 2022. Recurring revenue
increased 5%,
including
3% of negative im
pact from foreign currency fluctuations. The recurring revenue
increase
was due primarily to an
increase
in Public Cloud revenue from expansions and migrations. Recurring revenue also included a benefit from annual upfront software subscription revenue associated with on-premises subscription software of approximately 1% compared to the first nine months of 2022. The impact of recurring revenue recognized upfront is not expected to have a significant year-over-year impact on a full-year basis.
Revenues from perpetual software licenses, hardware and other were
down 31% in t
he first nine months of 2023, including
4
% of
adverse
impact from foreign currency fluctuations, as customers continue to transition to subscription-based offerings, consistent with our overall strategy.
Consulting services revenue
decreased
4%
in the first nine months of 2023, including a
3% negative
impact from foreign currency fluctuations. Our consulting business is starting to stabilize its revenue run-rate, following our strategic realignment to focus our consulting resources on higher-margin engagements, both direct engagement with customers and joint engagement with partners that drive increased software consumption within our targeted customer base. Consulting services revenue was also impacted by ceasing our operations in China and Russia.
Gross Profit
% of
% of
In millions
2023
Revenue
2022
Revenue
Recurring
$
810
72.3
%
$
769
72.4
%
Perpetual software licenses, hardware and other
3
9.1
%
14
29.2
%
Consulting services
24
10.8
%
35
15.0
%
Total gross profit
$
837
60.8
%
$
818
60.9
%
Recurring revenue gross profit as a percentage of revenue was relatively unchanged from the prior year, as the impact of a larger percentage of Public Cloud revenue was mostly offset by improvements in that Public Cloud margin rate.
The
decrease in p
erpetual software licenses, hardware and other gross profit as a percentage of revenue was primarily driven by deal mix and overall lower revenue volume as compared to the prior year.
Consulting services gross profit as a percentage of revenue
decreased a
s compared to the prior year primarily due to headcount expenses and delayed project timelines. We continue to refocus our consulting organization on Vantage-oriented offerings and reduce our footprint in non-core consulting engagements.
SG&A expenses were relatively unchanged from the prior-year period.
R&D ex
penses decreased for the first
nine
months of 2023 as compared to prior ye
ar, due to continued cost discipline and lower outside services costs.
Other Expense, net
In millions
2023
2022
Interest income
$
22
$
9
Interest expense
(22)
(17)
Other
(44)
(34)
Other expense, net
$
(44)
$
(42)
Other expense, net for the nine months of 2023 and 2022 is comprised primarily of interest expense on long-term debt and finance leases, losses resulting from foreign currency transactions, and benefit costs associated with our pension and postemployment plans, partially offset by interest income earned on our cash and cash equivalents. Other expense is
higher i
n 2023 primarily due to
$9 million higher losses re
sulting from foreign currency transactions compared to the prior period.
As disclosed in Note 13 of Notes to Condensed Consolidated Financial Statements (Unaudited), during October of 2023, we began entering into Blue Chip Swap transactions in order to remit cash from our Argentine operations that will result in a pre-tax loss on investment of
$13 million
during the fourth quarter of 2023 that will be reported in "Other" expense in the fourth quarter of 2023.
Provision for Income Taxes
The effective tax rates for the nine months ended September 30, 2023 and 2022 were as follows:
2023
2022
Effective tax rate
27.4
%
38.5
%
For the nine months ended September 30, 2023, the Company recorded
$6 million of net discrete tax benefits, $3 million of which related to adjustments to the Company's accrual for unrecognized tax benefits in accordance with FIN 48 for the lapse of statute of limitations and $3 million related to the excess tax benefit derived from stock-based compensation vesting.
For the nine months ended September 30, 2022, the Company recorded $2 million
of net discrete tax benefits, a majority of which related to the excess tax benefit derived from $6 million of stock-based compensation vesting, offset by $5 million of discrete tax expense associated with valuation allowances against the current tax receivable and deferred tax asset balance that is not expected to be realized as a result of the discontinuation of the Company's business in Russia in the first quarter of 2022.
The following table presents segment revenue and segment gross profit for the Nine Months Ended September 30,:
% of
% of
In millions
2023
Revenue
2022
Revenue
Segment revenue
Americas
$
824
59.9
%
$
781
58.1
%
EMEA
348
25.3
%
337
25.1
%
APJ
204
14.8
%
225
16.8
%
Total segment revenue
$
1,376
100
%
$
1,343
100
%
Segment gross profit
Americas
$
521
63.2
%
$
493
63.1
%
EMEA
214
61.5
%
207
61.4
%
APJ
115
56.4
%
136
60.4
%
Total segment gross profit
$
850
61.8
%
$
836
62.2
%
Americas
Americas revenue was
up 6%
as compared to the prior year, and included
1% of negative
impact from foreign currency fluctuations. Recurring revenue was
up 7%,
while perpetual software licenses, hardware and other revenue
decreased 50% ($10 million). P
erpetual software licenses, hardware and other was
down
primarily due to the timing of transactions in the period, and the strategic shift towards recurring revenue. Consulting revenue
increased 4% ($4 million).
Segment gross profit as a percentage of revenues was slightly
higher with benefit from t
he gross profit associated with upfront revenue compared to the prior period largely offset by a higher mix of Public Cloud revenue.
EMEA
EMEA revenue
increased 3%,
which included a
2% adverse
impact from foreign currency fluctuations. The overall
increase in revenue included an increase of 9%
in recurring revenue, a
9% decrease in consulting revenue and a 20% ($4 million) decrease i
n perpetual software licenses, hardware and other revenue. Overall revenue was impacted by the
negative e
ffects of foreign currency and ceasing operations in Russia. Segment gross profit as a percentage of revenues was relatively unchanged from the prior year, as the benefit from a higher mix of recurring revenue was mostly offset in part by the
negative
impact of currency fluctuations and ceasing operations in Russia.
APJ
APJ revenue
decreased 9%,
which included a
5% adverse
impact from foreign currency fluctuations. The overall
decrease i
n revenue included a
decrease
in recurring revenue of
8%
, a
decrease in consulting revenue of 11% ($7 million)
, and a
decrease in p
erpetual software licenses, hardware and other revenue of
13% ($1 million).
Segment gross profit as a percentage of revenues was
negatively impacted by reduced
revenues, which include the wind-down of direct operations in China that started earlier this year.
Financial Condition, Liquidity and Capital Resources
Cash provided by operating activities was
$199
million, which
decreased by $91
million in the nine months ended September 30, 2023 compared to the nine months ended September 30, 2022. The
decrease
in cash provided by operating activities was primarily due to a $50 million tax refund received the first quarter of 2022 related to our Cares Act carryback claim and
incremental cash taxes of $35 million in the second quarter of 2023.
Teradata used approximately
$30
million of cash in the first nine months of 2023 for reorganizing and restructuring its operations and go-to-market functions to align to its strategy, as compared to $20 million in the first nine months of 2022.
Teradata’s management uses a financial measure called "free cash flow," which is not a measure defined under GAAP. We use free cash flow (which we define as net cash provided by operating activities less investing activities related to capital expenditures for property and equipment and additions to capitalized software) as one measure of assessing the financial performance of the Company, and this may differ from the definitions used by other companies. The components that are used to calculate free cash flow are GAAP measures taken directly from the Condensed Consolidated Statements of Cash Flows (Unaudited). We believe that free cash flow information is useful for investors because it relates the operating cash flow of the Company to the capital that is spent to continue and improve business operations. In particular, free cash flow indicates the amount of cash available after capital expenditures, for among other things, investments in the Company’s existing businesses, strategic acquisitions and repurchases of Teradata common stock. Free cash flow does not represent the residual cash flow available for discretionary expenditures since there may be other non-discretionary expenditures that are not deducted from the measure. This non-GAAP measure should not be considered a substitute for, or superior to, cash flows from operating activities under GAAP.
The table below shows net cash provided by operating activities and net cash used in investing activities related to capital expenditures, along with free cash flow, for the following periods:
Nine Months Ended September 30,
In millions
2023
2022
Net cash provided by operating activities
$
199
$
290
Less:
Expenditures for property and equipment
(11)
(6)
Additions to capitalized software
(1)
(1)
Free cash flow
$
187
$
283
Financing activities and certain other investing activities, such as our strategic acquisition of Stemma Technologies during the third quarter of 2023, are not included in our calculation of free cash flow. The acquisition of Stemma Technologies was not financially material. There were
no other material inve
sting activities for the nine months ended September 30, 2023 and 2022. As disclosed in Note 13 of Notes to Condensed Consolidated Financial Statements (Unaudited), during October of 2023, we began entering into Blue Chip Swap transactions in order to remit cash from our Argentine operations that will result in a pre-tax loss on investment of
$13 million
during the fourth quarter of 2023 that will be reported as an investing activity for cash flow purposes in that period.
Teradata’s financing activities for the nine months ended September 30, 2023 and 2022 primarily consisted of cash outflows for share repurchases and payments on our finance leases. At September 30, 2023, we had
no outstanding
borrowings on our $400 million Revolving Facility (as defined below).
We have two share repurchase programs that were authorized by our Board of Directors:
•
The dilution offset share repurchase program allows us to repurchase Teradata common stock to the extent (i) cash is received from the exercise of stock options and (ii) employees' purchase Teradata stock pursuant to the Teradata Employee Stock Purchase Plan ("ESPP"). The purpose of the dilution offset share repurchase program is to offset dilution from shares issued pursuant to the exercise of stock options and shares purchased under the ESPP.
•
Our open market share repurchase program provides for the repurchase of Teradata stock periodically on an ongoing basis in open market transactions, through 10b5-1 programs, through accelerated share repurchase programs, in privately negotiated transactions, or through the use of derivative instruments, in accordance with applicable securities rules regarding issuer repurchases. The open market share repurchase program will expire on December 31, 2025. On November 1, 2021, our Board of Directors authorized an additional
$1 billion
for share repurchases under the open market share repurchase program. There is a total authority of
$560
million remai
ning under the open market share repurchase program as of September 30, 2023.
In the aggregate under the dilution offset share repurchase program and the open market share repurchase program, we repurchased approximately
6.9 million
shares of common stock at an average price per share of $
43.80
in the nine months ended September 30, 2023.
Share repurchases are reported on a trade date basis. Our share repurchase activity depends on factors such as our working capital needs, our cash requirements for capital investments, our stock price, and economic and market conditions.
Other financing activities, including net share settlement for the payroll tax liability of section 16 officers (as discussed in Item 2. Unregistered Sales of Equity Securities and Use of Proceeds), offset by proceeds from the ESPP and the exercise of stock options, net of tax was a net inflow of $6 million for the nine months ended September 30, 2023 and a net inflow of $6 million (including fees from the credit facility agreement) for the nine months ended September 30, 2022. The ESPP proceeds are included in other financing activities, net in the Condensed Consolidated Statements of Cash Flows (Unaudited).
Our total cash and cash equivalents held outside the United States in various foreign subsidiaries was
$297 million
as of September 30, 2023 and $405 million as of December 31, 2022. The remaining balance held in the United States ("U.S.") was
$51 million
as of September 30, 2023 and $164 million as of December 31, 2022. The Company expects that a majority of its foreign earnings will be repatriated to the U.S. Effective January 1, 2018, the U.S. moved to a territorial system of international taxation, and as such will generally not subject future foreign earnings to U.S. taxation upon repatriation in future years.
Management believes current cash, cash generated from operations and the
$400 million
available under the Credit Facility will be sufficient to satisfy future working capital, research and development activities, capital expenditures, pension contributions, and other financing requirements for at least the next twelve months. The Company principally holds its cash and cash equivalents in bank deposits and highly-rated money market funds.
The Company’s ability to generate positive cash flows from operations is dependent on general economic conditions, competitive pressures, and other business and risk factors described in the 2022 Annual Report and elsewhere in this Quarterly Report on Form 10-Q. If the Company is unable to generate sufficient cash flows from operations, or otherwise comply with the terms of the Credit Facility or its term loan agreement, the Company may be required to seek additional financing alternatives.
Long-term Debt.
On June 28, 2022, we entered into a Credit Agreement that provides for (i) a five-year unsecured term loan in an aggregate principal amount of $500 million (the "Term Loan"), and (ii) a five-year unsecured revolving credit facility in an aggregate principal amount of up to $400 million, including a $50 million sublimit for the issuance of standby letters of credit and a $50 million sublimit for swingline loans (the "Revolving Facility" and, collectively with the Term Loan, the "Credit Facility").
The Credit Facility replaces our prior revolving credit agreement in the maximum principal of $400 million and our prior term loan agreement in the principal amount of $500 million, both of which were entered into in 2018 (the "Prior Agreements"). In connection with the execution of the Credit Facility, the $400 million term loan outstanding under the Prior Agreements was repaid in full. Our long-term debt is discussed in Note 10 of Notes to Condensed Consolidated Financial Statements (Unaudited). In addition, as disclosed in Note 7 of Notes to Condensed Consolidated Financial Statements (Unaudited), Teradata entered into an interest rate swap to hedge approximately 90% of the floating interest rate of the total $500 million Term Loan and a cross currency swap to hedge a portion of Euro currency exposure of its net investment in certain foreign subsidiaries.
On September 21, 2023, the Credit Agreement was amended to establish key performance indicators with respect to certain environmental, social, and governance ("ESG") targets, pursuant to which certain positive or negative adjustments would be made to various fees and applicable margin based on Teradata’s performance against such ESG targets.
Contractual and Other Commercial Commitments.
There has been no significant change in our contractual and other commercial commitments as described in the 2022 Annual Report. Our commitments and contingencies are discussed in Note 8 of Notes to Condensed Consolidated Financial Statements (Unaudited).
Critical Accounting Policies and Estimates
Our financial statements are prepared in accordance with GAAP. In connection with the preparation of these financial statements, we are required to make assumptions, estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses and the related disclosure of contingent liabilities. These assumptions, estimates and judgments are based on historical experience and assumptions that are believed to be reasonable at the time. However, because future events and their effects cannot be determined with certainty, the determination of estimates requires the exercise of judgment. Our critical accounting policies are those that require assumptions to be made about matters that are highly uncertain. Different estimates could have a material impact on our financial results. Judgments and uncertainties affecting the application of these policies and estimates may result in materially different amounts being reported under different conditions or circumstances. Our management periodically reviews these estimates and assumptions to ensure that our financial statements are presented fairly and are materially correct.
We assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to us as of September 30, 2023 and through the date of this report. The accounting matters assessed included, but were not limited to, our allowance for doubtful accounts, stock-based compensation, the carrying value of our goodwill and other long-lived assets, financial assets, valuation allowances for tax assets and revenue recognition.
In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require significant management judgment in its application. There are also areas in which management’s judgment in selecting among available alternatives would not produce a materially different result. The significant accounting policies and estimates that we believe are the most critical to aid in fully understanding and evaluating our reported financial results are discussed in the 2022 Annual Report. Teradata’s senior management has reviewed these critical accounting policies and related disclosures and determined that there were no significant changes in our critical accounting policies in the nine months ended September 30, 2023.
New Accounting Pronouncements
See discussion in Note 2 of Notes to Condensed Consolidated Financial Statements (Unaudited) for new accounting pronouncements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
There have not been any material changes to the market risk factors previously disclosed in Part II, Item 7A of the 2022 Annual Report.
Teradata maintains a system of disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) that are designed to provide reasonable assurance that information required to be disclosed in its reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including, as appropriate, the Chief Executive Officer and the Chief Financial Officer, to allow timely decisions regarding required disclosures. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.
Based on their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2023, our disclosure controls and procedures were effective to provide reasonable assurance that the information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
There have been no changes in our internal control over financial reporting that occurred during the fiscal quarter ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Part II—OTHER INFORMATION
Item 1. Legal Proceedings.
The information required to be set forth under this Part II, Item 1 is incorporated by reference to Note 8, Commitments and Contingencies—Legal Proceedings of the Notes to Condensed Consolidated Financial Statements (Unaudited) included in this Quarterly Report on Form 10-Q.
Item 1A. Risk Factors.
There have not been any material changes to the risk factors previously disclosed in Part I, Item IA of the 2022 Annual Report.
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities.
Purchases of Company Common Stock
From time to time, the Company's Section 16 officers sell to the Company shares of the Company's common stock received upon vesting of restricted share units at the current market price to cover their withholding tax obligations. For the nine months ended September 30, 2023, the total of these purchases was 405,004 shares
at an average price of $40.45
per share.
The following table provides information relating to the Company’s share repurchase programs for the nine months ended September 30, 2023:
Total
Number
of Shares Purchased
Average
Price
Paid
per Share
Total
Number
of Shares
Purchased
as Part of
Publicly
Announced
Dilution
Offset Program
(1)
Total
Number
of Shares
Purchased
as Part of
Publicly
Announced
Open Market Share
Repurchase Program
(2)
Maximum
Dollar
Value
that May
Yet Be
Purchased
Under the
Dilution
Offset Program
Maximum
Dollar
Value
that May
Yet Be
Purchased
Under the
Open Market Share
Repurchase Program
Month
January 2023
578,953
$
33.68
—
578,953
$
94,032
$
820,700,472
February 2023
651,185
$
39.17
—
651,185
$
219,974
$
795,191,860
March 2023
1,091,968
$
38.92
137,380
954,588
$
1,072,676
$
758,232,193
First Quarter Total
2,322,106
$
37.69
137,380
2,184,726
$
1,072,676
$
758,232,193
April 2023
671,920
$
39.93
—
671,920
$
1,103,891
$
731,404,630
May 2023
360,229
$
43.12
—
360,229
$
1,942,445
$
715,872,872
June 2023
578,234
$
51.88
56,144
522,090
$
5,553,859
$
688,873,071
Second Quarter Total
1,610,383
$
44.93
56,144
1,554,239
$
5,553,859
$
688,873,071
July 2023
697,567
$
55.13
106,032
591,535
$
253,275
656,182,580
August 2023
1,337,144
$
46.54
—
1,337,144
$
433,557
593,954,290
September 2023
903,470
$
44.72
147,370
756,100
$
409,123
560,227,734
Third Quarter Total
2,938,181
$
48.02
253,402
2,684,779
$
409,123
$
560,227,734
(1) The dilution offset share repurchase program allows the Company to repurchase Teradata common stock to the extent of cash received from the exercise of stock options and purchases under the ESPP to offset dilution from shares issued pursuant to these plans.
(2) The open market share repurchase program authorized by the Board allows the Company to repurchase outstanding shares of Teradata common stock. Share repurchases made by the Company are reported on a trade date basis. The open market share repurchase program expires on December 31, 2025.
During the three months ended September 30, 2023, other than the officers shown in the table below, no other director or officer of the Company
adopted
or
terminated
a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.
Name (Title)
Action
Date
Trading Arrangement
Total Shares to be Sold
Expiration Date
Rule 10b5-1*
Non-Rule 10b5-1**
Todd M. Cione
(
Chief Revenue Officer
)
Adopt
8/31/2023
x
Up to
75,925
(1)
8/14/2024
Kathleen Cullen-Cote
(
Chief People Officer
)
Adopt
8/11/2023
x
Up to
43,737
11/12/2024
* Intended to satisfy the affirmative defense of Rule 10b5-1(c).
**Not intended to satisfy the affirmative defense of Rule 10b5-1(c).
(1)
Mr. Cione’s Rule 10b5-1 trading arrangement includes the sale of (i) 8,877 shares of common stock, and (ii) 50% of the net shares (not yet determinable) after shares are withheld to satisfy tax obligations upon the vesting of 90,128 restricted share units (“RSUs”) and 43,967 performance-based RSUs (which such number for purposes of this disclosure is based on the target amount of performance-based RSUs granted to Mr. Cione in 2021, but the number of shares of common stock subject to Mr. Cione’s plan may vary based on the Company’s actual performance achieved at the end of the applicable 2023 performance period for the performance-based RSUs).
Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Customers and Suppliers of TERADATA CORP /DE/
Beta
No Customers Found
No Suppliers Found
Bonds of TERADATA CORP /DE/
Price Graph
Price
Yield
Insider Ownership of TERADATA CORP /DE/
company Beta
Owner
Position
Direct Shares
Indirect Shares
AI Insights
Summary Financials of TERADATA CORP /DE/
Beta
(We are using algorithms to extract and display detailed data. This is a hard problem and we are working continuously to classify data in an accurate and useful manner.)